4van Doom P A, Ruts L, Jacobs B C. Clinical features, pathogenesis, and treatment of GuiUain - Barr6 syndrome. Lancet Neurol, 2008,7 : 939 - 950.
5van der Meche FG, van Doom PA. Guillain - Barre syndrome and chronic inflammatory demyelinating polyneuropathy : immune mechanisms and update on current therapies. Ann Neurol, 1995,37 (suppl 1) : S14 -31.
7Sejvar J J, Baughman A L, Wise M, et al. Population Incidence of Guillain-Barr6 Syndrome: A Systematic Re- view and Meta-Analysis [ J ]. Neuroepidemiology, 2011, 36(2) :123-133.
8Talukder R K, Sutradhar S R, Rahman K M, et al, Guillian-Barre syndrome[ J ]. Mymensingh Med J, 2011, 20(4) :748-756.
9Franca M C Jr, Deus-Silva L, de Castro R, et al. Guil- lain-Barr6 syndrome in the elderly: clinical, electrophys- iologieal, therapeutic and outcome features[ J]. Arg Neu- ropsiquiatr, 2005,63 (3B) :772-775.
